Cadila Healthcare: Potential More than 30% Upside.
Cadila Healthcare Ltd (CDH IN) is the 4th largest pharmaceutical company in India and 9th largest generic drug company in the U.S. At FY 2018 P/E...
195 Views
No Trump Cards for This Risk
This Insight is an update from Generic Drug Antitrust Inquiry: A Primer. Several generic drug companies caught up in government investigations into...
252 Views
Generic Drug Antitrust Inquiry: A Primer
Recent news stories reporting looming criminal antitrust charges against certain generic drug companies (and possibly executives) are wighing on...
211 Views
Another Post-Trump Trade: Revisiting Sun Pharmaceuticals (SUNP IN) After Q2 (FY2017) Earnings
We initiated coverage on Sun Pharmaceutical Indus (SUNP IN) with Buy rating and common stock price target of INR 855 earlier this month. Link to...
185 Views
President Trump and Healthcare (And Pharma) Sector: What's Next?
Now that the initial shock period is over, we return to finding out how President Trump could affect the U.S. (and with it the global) healthcare...
262 Views